CONCORD BIOTECH
|
The Current P/S Ratio of CONCORD BIOTECH is 14.82.
Share Price | ₹1,699.9 | Aug 05,2025 |
Market Cap | ₹17,781.0 Cr | |
Sales-TTM | ₹1,200.1 Cr | TTM-Consolidated Results |
Price/Sales | 14.82x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹17,781.0 Cr] as on Aug 05,2025
(/) Sales [ ₹1,200.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 14.82x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay '14.82 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !
The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH
PS Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.13x.
- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.
- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
CONCORD BIOTECH | 1,200.1 | 14.82 | 17,781.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.28 | 391,607.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.18 | 170,148.0 |
CIPLA LTD | 27,811.2 | 4.35 | 121,103.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.26 | 121,471.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.02 | 101,306.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.34 | 108,009.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.16 | 96,608.5 |
LUPIN LTD | 22,707.9 | 3.75 | 85,108.0 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.96 | 62,726.6 |
ABBOTT INDIA LTD | 6,409.2 | 11.03 | 70,676.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.96x |
Max industry PS | 18.18x |
Median industry PS | 7.28x |
Average industry PS | 7.92x |
You may also like the below Video Courses